National Information Center on Health Services Research and Health Care Technology (NICHSR)
HTA 101: About the Author
Clifford S. Goodman is a Vice President and Senior Scientist at The Lewin Group, a health care policy and management consulting firm based in Falls Church, Virginia, near Washington, DC. He has more than 20 years of experience in health care evaluation, primarily devoted to assessment of health care technology and related policy analyses. Dr. Goodman's expertise involves technology assessment, evidence appraisal, outcomes research, health economics, decision analytic modeling, and studies pertaining to health care innovation, diffusion, and payment. He has worked with an international range of government agencies; pharmaceutical, biotechnology, and medical device companies; health care provider institutions; and professional and industry associations. On behalf of the US Agency for Healthcare Research and Quality (AHRQ), he is the Director of the Evidence-based Practice Centers Coordinating Center at The Lewin Group.
Dr. Goodman has worked in such diverse technological areas as heart assist devices, interventional cardiology, hypertension management, diagnostic testing, diagnostic imaging, organ and tissue donation, blood supply safety, national cancer policy, substance abuse treatment, and telemedicine. His work on databases in health technology assessment and health services research contributed to the development of the HealthSTAR (now incorporated into MEDLINE) and HSRProj databases of the National Library of Medicine. Dr. Goodman has testified before the US Congress on issues pertaining to Medicare coverage of health care technology. He is a member of the Medicare Coverage and Advisory Committee (MCAC) of the US Centers for Medicare and Medicaid Services (CMS).
Earlier in his career, as a National Research Council Fellow and later as director of the Council on Health Care Technology, he managed and staffed a series of technology assessment projects at the Institute of Medicine of the US National Academy of Sciences, including the landmark study, Assessing Medical Technologies. Subsequently, Dr. Goodman was a visiting researcher at the Swedish Council on Technology Assessment in Health Care in Stockholm.
Dr. Goodman is a board member of HTA International (HTAi) and is a Fellow of the American Institute for Medical and Biological Engineering. He did his undergraduate work at Cornell University, received a master's degree from the Georgia Institute of Technology, and earned his doctorate from the Wharton School of the University of Pennsylvania.